FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marion De Jong

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Tissue Distribution

Disorders

Anatomy

Co-author Network

Publications

TOP 3
T M Piscaer; M Sandker; O P van der Jagt; J A N Verhaar; Marion De Jong; Harrie Weinans
Real-time assessment of bone metabolism in small animal models for osteoarthritis using multi pinhole-SPECT/CT.
Stefan E Pool; Linda M van der Graaf; Sander Bison; Stuart J Koelewijn; Eric P Krenning; Marleen Melis; Marion De Jong
mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer.
Esther I van Vliet; Jaap J M Teunissen; Marion De Jong; Boen L Kam; Eric P Krenning; Dik J Kwekkeboom
Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marion De Jong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: T M Piscaer; M Sandker; O P van der Jagt; J A N Verhaar; Marion De Jong; Harrie Weinans
Real-time assessment of bone metabolism in small animal models for osteoarthritis using multi pinhole-SPECT/CT.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2013;21(6):882-8.
2013: Stefan E Pool; Linda M van der Graaf; Sander Bison; Stuart J Koelewijn; Eric P Krenning; Marleen Melis; Marion De Jong
mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer.
Cancer research 2013;73(1):12-8.
2013: Esther I van Vliet; Jaap J M Teunissen; Marion De Jong; Boen L Kam; Eric P Krenning; Dik J Kwekkeboom
Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.
Neuroendocrinology 2013;97(1):74-85.
2012: R P J Schroeder; Wytske M Van Weerden; Wouter A P Breeman; Erik De Blois; Corrina M A de Ridder; Marion De Jong
Improving radiopeptide pharmacokinetics by adjusting experimental conditions for bombesin receptor-targeted imaging of prostate cancer.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2012;56(5):468-75.
2012: Marleen Melis; Roelf Valkema; Eric P Krenning; Marion De Jong
Reduction of renal uptake of radiolabeled octreotate by amifostine coadministration.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(5):749-53.
2011: Luigi Aloj; Michela Aurilio; Karin Beetschen; Wouter A P Breeman; Laura D'ambrosio; Erik De Blois; Lieke Joosten; Stuart Koelewijn; Theodosia Maina; Rosalba Mansi; Marleen Melis; Petra Kolenc Peitl; Jean Claude Reubi; Valentina Rinaldi; Jane K Sosabowski; Diego Tesauro; Elisabeth von Guggenberg; Beatrice Waser; Marion De Jong
Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.
European journal of nuclear medicine and molecular imaging 2011;38(8):1417-25.
2011: Peter Laverman; Helmut R Mäcke; Theodosia Maina; Wim J G Oyen; Petra Kolenc Peitl; Jean-Claude Reubi; Susan Roosenburg; Jane K Sosabowski; Elisabeth von Guggenberg; Luigi Aloj; Marion De Jong; Annemarie Eek; Lieke Joosten; Otto C Boerman
Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides.
European journal of nuclear medicine and molecular imaging 2011;38(8):1410-6.
2011: Rogier P J Schroeder; Wytske M Van Weerden; Eric P Krenning; Chris H Bangma; S Berndsen; C H Grievink-de Ligt; H C Groen; S Reneman; Erik De Blois; Wouter A P Breeman; Marion De Jong
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.
European journal of nuclear medicine and molecular imaging 2011;38(7):1257-66.
2011: Mark W Konijnenberg; Marion De Jong
Preclinical animal research on therapy dosimetry with dual isotopes.
European journal of nuclear medicine and molecular imaging 2011;38 Suppl 1():S19-27.
2011: François-Xavier Hanin; Stanislas Pauwels; Anne Bol; Marleen Melis; Wout Breeman; Marion De Jong; François Jamar
Effect of interferon-alpha treatment on [68Ga-DOTA,Tyr3,Thre8]octreotide uptake in CA20948 tumors: a small-animal PET study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(4):580-5.
2011: Erik Vegt; Marleen Melis; Annemarie Eek; Monique de Visser; Maarten Brom; Wim J G Oyen; Martin Gotthardt; Marion De Jong; Otto Boerman
Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice.
European journal of nuclear medicine and molecular imaging 2011;38(4):623-32.
2011: O P van der Jagt; T M Piscaer; W Schaden; Jianjun Li; N Kops; Holger Jahr; Jacqueline C van der Linden; Jan H Waarsing; Jan verhaar; Marion De Jong; Harrie Weinans
Unfocused extracorporeal shock waves induce anabolic effects in rat bone.
The Journal of bone and joint surgery. American volume 2011;93(1):38-48.
2011: Lejla Alic; Monique Bernsen; Karin Bol; Marion De Jong; Joost C Haeck; Stefan Klein; Wiro J Niessen; Sandra T van Tiel; Piotr A Wielepolski; Jifke F Veenland
Facilitating tumor functional assessment by spatially relating 3D tumor histology and in vivo MRI: image registration approach.
PloS one 2011;6(8):e22835.
2010: Marleen Melis; Jan de Swart; Monique de Visser; Saskia C Berndsen; Stuart Koelewijn; Roelf Valkema; Otto C Boerman; Eric P Krenning; Marion De Jong
Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(12):1962-8.
2010: Erik Vegt; Marion De Jong; Jack F M Wetzels; Rosalinde Masereeuw; Marleen Melis; Wim J G Oyen; Martin Gotthardt; Otto Boerman
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(7):1049-58.
2010: Rogier P J Schroeder; Cristina Müller; Suzanne Reneman; Marleen L Melis; Wouter A P Breeman; Erik De Blois; Chris H Bangma; Eric P Krenning; Wytske M Van Weerden; Marion De Jong
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.
European journal of nuclear medicine and molecular imaging 2010;37(7):1386-96.
2010: Rogier P J Schroeder; Monique de Visser; Wytske M Van Weerden; Corrina M A de Ridder; Suzanne Reneman; Marleen Melis; Wouter A P Breeman; Eric P Krenning; Marion De Jong
Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts.
International journal of cancer. Journal international du cancer 2010;126(12):2826-34.
2010: Marleen Melis; Erik Vegt; Mark W Konijnenberg; Monique de Visser; Magda Bijster; Marcel Vermeij; Eric P Krenning; Otto Boerman; Marion De Jong
Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(6):973-7.
2010: Stefan E Pool; Eric P Krenning; Gerben A Koning; C H J van Eijck; Jaap J M Teunissen; Boen L Kam; Roelf Valkema; Dik J Kwekkeboom; Marion De Jong
Preclinical and clinical studies of peptide receptor radionuclide therapy.
Seminars in nuclear medicine 2010;40(3):209-18.
2010: Edgar J Rolleman; Marleen Melis; Roelf Valkema; Otto Boerman; Eric P Krenning; Marion De Jong
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.
European journal of nuclear medicine and molecular imaging 2010;37(5):1018-31.
2010: Marion De Jong; Theodosia Maina
Of mice and humans: are they the same?--Implications in cancer translational research.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(4):501-4.
2010: Dik J Kwekkeboom; Boen L Kam; Martijn van Essen; Jaap J M Teunissen; C H J van Eijck; Roelf Valkema; Marion De Jong; Wouter W de Herder; Eric P Krenning
Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
Endocrine-related cancer 2010;17(1):R53-73.
2010: François-Xavier Hanin; Stanislas Pauwels; Anne Bol; Wout Breeman; Marion De Jong; François Jamar
Tumor uptake of 68Ga-DOTA-Tyr3-octreotate: animal PET studies of tumor flow and acute somatostatin receptor modulation in the CA20948 rat model.
Nuclear medicine and biology 2010;37(2):157-65.
2010: James R Mitchell; Mariëlle Verweij; Karl Brand; Marieke van de Ven; Natascha Goemaere; Sandra van den Engel; Timothy Chu; Flavio Forrer; Cristina Müller; Marion De Jong; Wilfred van IJcken; Jan N M Ijzermans; Jan H J Hoeijmakers; Ron W F de Bruin
Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice.
Aging cell 2010;9(1):40-53.
2010: Erik Vegt; Annemarie Eek; Wim J G Oyen; Marion De Jong; Martin Gotthardt; Otto Boerman
Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.
European journal of nuclear medicine and molecular imaging 2010;37(2):226-34.
2009: Marleen Melis; Magda Bijster; Monique de Visser; Mark W Konijnenberg; Jan de Swart; Edgar J Rolleman; Otto C Boerman; Eric P Krenning; Marion De Jong
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.
European journal of nuclear medicine and molecular imaging 2009;36(12):1968-76.
2009: Alida C Fröberg; Marion De Jong; Berthold A Nock; Wouter A P Breeman; Jack Erion; Theodosia Maina; Marion Verdijsseldonck; Wouter W de Herder; Aad van Der Lugt; Peter P M Kooij; Eric P Krenning
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
European journal of nuclear medicine and molecular imaging 2009;36(8):1265-72.
2009: Marion De Jong; Wouter A P Breeman; Dik J Kwekkeboom; Roelf Valkema; Eric P Krenning
Tumor imaging and therapy using radiolabeled somatostatin analogues.
Accounts of chemical research 2009;42(7):873-80.
2009: Cheng-Bin Yim; Otto Boerman; Monique de Visser; Marion De Jong; Annemarie C Dechesne; Dirk T S Rijkers; Rob M J Liskamp
Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers.
Bioconjugate chemistry 2009;20(7):1323-31.
2009: Martijn van Essen; Eric P Krenning; Boen L Kam; Marion De Jong; Roelf Valkema; Dik J Kwekkeboom
Peptide-receptor radionuclide therapy for endocrine tumors.
Nature reviews. Endocrinology 2009;5(7):382-93.
2009: Flavio Forrer; Eric P Krenning; Peter P M Kooij; Bert F Bernard; Mark W Konijnenberg; Willem H Bakker; Jaap J M Teunissen; Marion De Jong; Kirsten van Lom; Wouter W de Herder; Dik J Kwekkeboom
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate.
European journal of nuclear medicine and molecular imaging 2009;36(7):1138-46.
2008: Wouter A P Breeman; A C Fröberg; Erik De Blois; Arthur van Gameren; Marleen Melis; Marion De Jong; T Maina; B A Nock; Jack Erion; H R Mäcke; Eric P Krenning
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides.
Nuclear medicine and biology 2008;35(8):839-49.
2008: Mariam Kouch-el Filali; Emine Kilic; Marleen Melis; Annelies de Klein; Marion De Jong; Gregorius P M Luyten
Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2008;246(11):1585-92.
2008: Erik Vegt; Julliëtte E M van Eerd; Annemarie Eek; Wim J G Oyen; Jack F M Wetzels; Marion De Jong; Frans G M Russel; Rosalinde Masereeuw; Martin Gotthardt; Otto Boerman
Reducing renal uptake of radiolabeled peptides using albumin fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1506-11.
2008: Monique de Visser; Suzanne M Verwijnen; Marion De Jong
Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
Cancer biotherapy & radiopharmaceuticals 2008;23(2):137-57.
2008: Cristina Müller; Roger Schibli; Eric P Krenning; Marion De Jong
Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(4):623-9.
2008: Cristina Müller; Flavio Forrer; Roger Schibli; Eric P Krenning; Marion De Jong
SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(2):310-7.
2008: Peter Laverman; Susan Roosenburg; Martin Gotthardt; Jeseong Park; Wim J G Oyen; Marion De Jong; Mark R Hellmich; Floris P J T Rutjes; Floris L van Delft; Otto Boerman
Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
European journal of nuclear medicine and molecular imaging 2008;35(2):386-92.
2008: Edgar J Rolleman; Bert F Bernard; Wouter A P Breeman; Flavio Forrer; Erik De Blois; J Hoppin; M Gotthardt; Otto Boerman; Eric P Krenning; Marion De Jong
Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats.
Nuklearmedizin. Nuclear medicine 2008;47(3):110-5.
2007: Marleen Melis; Flavio Forrer; Astrid Capello; Magda Bijster; Bert F Bernard; Jean Claude Reubi; Eric P Krenning; Marion De Jong
Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2007;51(4):324-33.
2007: Maarten ter Horst; Eric Brouwer; Suzanne M Verwijnen; Mark Rodijk; Marion De Jong; Rob Hoeben; Bertie de Leeuw; Peter Sillevis Smitt
Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus.
The journal of gene medicine 2007;9(12):1071-9.
2007: Edgar J Rolleman; Peter P M Kooij; Wouter W de Herder; Roelf Valkema; Eric P Krenning; Marion De Jong
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney.
European journal of nuclear medicine and molecular imaging 2007;34(11):1854-60.
2007: Marleen Melis; Eric P Krenning; Bert F Bernard; Monique de Visser; Edgar J Rolleman; Marion De Jong
Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences.
Nuclear medicine and biology 2007;34(6):633-41.
2007: Cristina Müller; Roger Schibli; Flavio Forrer; Eric P Krenning; Marion De Jong
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys.
Nuclear medicine and biology 2007;34(6):603-8.
2007: Monique de Visser; H F Bernard; Jack Erion; Michelle A Schmidt; Ananth Srinivasan; B Waser; Jean Claude Reubi; Eric P Krenning; Marion De Jong
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.
European journal of nuclear medicine and molecular imaging 2007;34(8):1228-38.
2007: Flavio Forrer; Edgar J Rolleman; Nils Schramm; Eric P Krenning; Marion De Jong
Is it possible to predict renal function in small animals using a multi-pinhole SPECT system.
European journal of nuclear medicine and molecular imaging 2007;34(7):1127-8.
2007: Paul J J M Janssen; Monique de Visser; Suzanne M Verwijnen; Bert F Bernard; Ananth Srinivasan; Jack Erion; Wouter A P Breeman; Arnold G Vulto; Eric P Krenning; Marion De Jong
Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumors.
Cancer biotherapy & radiopharmaceuticals 2007;22(3):374-81.
2007: Wouter A P Breeman; Dik J Kwekkeboom; Erik De Blois; Marion De Jong; Theo J Visser; Eric P Krenning
Radiolabelled regulatory peptides for imaging and therapy.
Anti-cancer agents in medicinal chemistry 2007;7(3):345-57.
2007: Gráinne B Biddlecombe; Buck E Rogers; Monique de Visser; Jesse J Parry; Marion De Jong; Jack Erion; Jason S Lewis
Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).
Bioconjugate chemistry 2007;18(3):724-30.
2007: Edgar J Rolleman; Flavio Forrer; Bert Bernard; Magda Bijster; Marcel Vermeij; Roelf Valkema; Eric P Krenning; Marion De Jong
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
European journal of nuclear medicine and molecular imaging 2007;34(5):763-71.
2007: Martin Gotthardt; Julliëtte van Eerd-Vismale; Wim J G Oyen; Marion De Jong; Hanwen Zhang; Edgar J Rolleman; Helmut R Maecke; Martin Béhé; Otto Boerman
Indication for different mechanisms of kidney uptake of radiolabeled peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):596-601.
2007: Flavio Forrer; Roelf Valkema; Dik J Kwekkeboom; Marion De Jong; Eric P Krenning
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
Best practice & research. Clinical endocrinology & metabolism 2007;21(1):111-29.
2007: Cristina Müller; Flavio Forrer; Bert F Bernard; Marleen Melis; Mark W Konijnenberg; Eric P Krenning; Marion De Jong
Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):151-9.
2007: Flavio Forrer; Edgar J Rolleman; Magda Bijster; Marleen Melis; Bert Bernard; Eric P Krenning; Marion De Jong
From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):40-9.
2007: Edgar J Rolleman; Eric P Krenning; Bert F Bernard; Monique de Visser; Magda Bijster; Theo J Visser; Marcel Vermeij; Jan Lindemans; Marion De Jong
Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in rats.
European journal of nuclear medicine and molecular imaging 2007;34(2):219-27.
2007: Martijn van Essen; Eric P Krenning; Marion De Jong; Roelf Valkema; Dik J Kwekkeboom
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.
Acta oncologica (Stockholm, Sweden) 2007;46(6):723-34.
2007: Mark W Konijnenberg; Marleen Melis; Roelf Valkema; Eric P Krenning; Marion De Jong
Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(1):134-42.
2007: Monique de Visser; Wytske M Van Weerden; Corrina M A de Ridder; Suzanne Reneman; Marleen Melis; Eric P Krenning; Marion De Jong
Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(1):88-93.
2007: Edgar J Rolleman; Flavio Forrer; Jaap Deckers; Hans de Groot; Roelf Valkema; Marion De Jong; Eric P Krenning
Anaphylactoid reaction from amifostine.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;82(1):110-1; author reply 111.
2006: Edgar J Rolleman; Marion De Jong; Roelf Valkema; Dik J Kwekkeboom; Boen L Kam; Eric P Krenning
Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1730-1; author reply 1731.
2006: Flavio Forrer; Roelf Valkema; Bert Bernard; Nils Schramm; J W Hoppin; Edgar J Rolleman; Eric P Krenning; Marion De Jong
In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals.
European journal of nuclear medicine and molecular imaging 2006;33(10):1214-7.
2006: Maarten ter Horst; Suzanne M Verwijnen; Eric Brouwer; Rob Hoeben; Marion De Jong; Bertie de Leeuw; Peter A E Sillevis Smitt
Locoregional delivery of adenoviral vectors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1483-9.
2006: Theodosia Maina; Berthold A Nock; Paul Cordopatis; Bert F Bernard; Wouter A P Breeman; Arthur van Gameren; Ria van den Berg; Jean Claude Reubi; Eric P Krenning; Marion De Jong
[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.
European journal of nuclear medicine and molecular imaging 2006;33(7):831-40.
2006: Edgar J Rolleman; Roelf Valkema; Marleen Melis; Marion De Jong; Eric P Krenning; Theo J Visser; Edgar J Rolleman
Cubilin and megalin in radiation-induced renal injury with labelled somatostatin analogues: are we just dealing with the kidney?
European journal of nuclear medicine and molecular imaging 2006;33(6):749-50.
2006: Astrid Capello; Eric P Krenning; Bert F Bernard; Wouter A P Breeman; Jack Erion; Marion De Jong
Anticancer activity of targeted proapoptotic peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(1):122-9.
2005: Suzanne M Verwijnen; Eric P Krenning; Roelf Valkema; Jan G M Huijmans; Marion De Jong
Oral versus intravenous administration of lysine: equal effectiveness in reduction of renal uptake of [111In-DTPA]octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2057-60.
2005: stephan walrand; François Jamar; Marion De Jong; Stanislas Pauwels
Evaluation of novel whole-body high-resolution rodent SPECT (Linoview) based on direct acquisition of linogram projections.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(11):1872-80.
2005: Astrid Capello; Eric P Krenning; Bert Bernard; Jean Claude Reubi; Wouter A P Breeman; Marion De Jong
111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
European journal of nuclear medicine and molecular imaging 2005;32(11):1288-95.
2005: Marion De Jong; Raffaella Barone; Eric P Krenning; Bert Bernard; Marleen Melis; Theo Visser; Michael Gekle; Thomas E Willnow; stephan walrand; François Jamar; Stanislas Pauwels
Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(10):1696-700.
2005: Marleen Melis; Eric P Krenning; Bert F Bernard; Raffaella Barone; Theo J Visser; Marion De Jong
Localisation and mechanism of renal retention of radiolabelled somatostatin analogues.
European journal of nuclear medicine and molecular imaging 2005;32(10):1136-43.
2005: Jaap J M Teunissen; Dik J Kwekkeboom; Marion De Jong; Jan-Paul Esser; Roelf Valkema; Eric P Krenning
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
Best practice & research. Clinical gastroenterology 2005;19(4):595-616.
2005: Wouter A P Breeman; Marion De Jong; Erik De Blois; Bert F Bernard; Mark W Konijnenberg; Eric P Krenning
Radiolabelling DOTA-peptides with 68Ga.
European journal of nuclear medicine and molecular imaging 2005;32(4):478-85.
2005: Leo J Hofland; Astrid Capello; Eric P Krenning; Marion De Jong; Martin P van Hagen
Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():191S-8S.
2005: Roelf Valkema; Stanislas Pauwels; Larry K Kvols; Dik J Kwekkeboom; François Jamar; Marion De Jong; Raffaella Barone; stephan walrand; Peter P M Kooij; Willem H Bakker; Janet Lasher; Eric P Krenning
Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():83S-91S.
2005: Eric P Krenning; Roelf Valkema; Dik J Kwekkeboom; Wouter W de Herder; C H J van Eijck; Marion De Jong; Stanislas Pauwels; Jean Claude Reubi
Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():76S-82S.
2005: Marion De Jong; Wouter A P Breeman; Roelf Valkema; Bert F Bernard; Eric P Krenning
Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():13S-7S.
2004: Astrid Capello; Eric P Krenning; Bert F Bernard; Wouter A P Breeman; Martin P van Hagen; Marion De Jong
Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1716-20.
2004: Wouter A P Breeman; Maarten Th M De Jong; Erik De Blois; Bert F Bernard; Marion De Jong; Eric P Krenning
Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+.
Nuclear medicine and biology 2004;31(6):821-4.
2004: Mark W Konijnenberg; Magda Bijster; Eric P Krenning; Marion De Jong
A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1260-9.
2004: Marion De Jong; Roelf Valkema; Arthur van Gameren; Hester Van Boven; Axel Bex; Eric Pieter Van De Weyer; Jan Dirk Burggraaf; Meike Körner; Jean Claude Reubi; Eric P Krenning
Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1168-71.
2004: Suzanne M Verwijnen; Astrid Capello; Bert Bernard; Gerard van den Aardweg; Mark W Konijnenberg; Wouter A P Breeman; Eric P Krenning; Marion De Jong
Low-dose-rate irradiation by 131I versus high-dose-rate external-beam irradiation in the rat pancreatic tumor cell line CA20948.
Cancer biotherapy & radiopharmaceuticals 2004;19(3):285-92.
2004: Bert Bernard; Astrid Capello; Martin P van Hagen; Wouter A P Breeman; Ananth Srinivasan; Michelle Schmidt; Jack Erion; Arthur van Gameren; Eric P Krenning; Marion De Jong
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):173-80.
2004: Eric P Krenning; Dik J Kwekkeboom; Roelf Valkema; Stanislas Pauwels; Larry K Kvols; Marion De Jong
Peptide receptor radionuclide therapy.
Annals of the New York Academy of Sciences 2004;1014():234-45.
2004: Edgar J Rolleman; Eric P Krenning; Arthur van Gameren; Bert F Bernard; Marion De Jong
Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructose.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):709-13.
2004: Suzanne M Verwijnen; Peter A E Sillevis Smith; Rob Hoeben; Martin J W E Rabelink; Leonard Wiebe; David T Curiel; Akseli Hemminki; Eric P Krenning; Marion De Jong
Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene.
Cancer biotherapy & radiopharmaceuticals 2004;19(1):111-20.
2003: Astrid Capello; Eric P Krenning; Wouter A P Breeman; Bert F Bernard; Mark W Konijnenberg; Marion De Jong
Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.
Cancer biotherapy & radiopharmaceuticals 2003;18(5):761-8.
2003: Monique de Visser; P J J M Janssen; Ananth Srinivasan; Jean Claude Reubi; B Waser; Jack Erion; Michelle A Schmidt; Eric P Krenning; Marion De Jong
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
European journal of nuclear medicine and molecular imaging 2003;30(8):1134-9.
2003: Wouter A P Breeman; Marion De Jong; Theo J Visser; Jack Erion; Eric P Krenning
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities.
European journal of nuclear medicine and molecular imaging 2003;30(6):917-20.
2003: Wouter A P Breeman; Amir Mearadji; Astrid Capello; Bert F Bernard; C H J van Eijck; Eric P Krenning; Marion De Jong
Anti-tumor effect and increased survival after treatment with [177Lu-DOTA0,Tyr3]octreotate in a rat liver micrometastases model.
International journal of cancer. Journal international du cancer 2003;104(3):376-9.
2003: Dik J Kwekkeboom; Willem H Bakker; Boen L Kam; Jaap J M Teunissen; Peter P M Kooij; Wouter W de Herder; Richard A Feelders; C H J van Eijck; Marion De Jong; Ananth Srinivasan; Jack Erion; Eric P Krenning
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.
European journal of nuclear medicine and molecular imaging 2003;30(3):417-22.
2003: Marion De Jong; Dik J Kwekkeboom; Roelf Valkema; Eric P Krenning
Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
European journal of nuclear medicine and molecular imaging 2003;30(3):463-9.
2003: Wouter A P Breeman; Katy van der Wansem; Bert F Bernard; Arthur van Gameren; Jack Erion; Theo J Visser; Eric P Krenning; Marion De Jong
The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
European journal of nuclear medicine and molecular imaging 2003;30(2):312-5.
2003: Astrid Capello; Eric P Krenning; Wouter A P Breeman; Bert F Bernard; Marion De Jong
Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(1):98-104.
2003: Edgar J Rolleman; Roelf Valkema; Marion De Jong; Peter P M Kooij; Eric P Krenning
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
European journal of nuclear medicine and molecular imaging 2003;30(1):9-15.
2002: Wouter A P Breeman; Marion De Jong; Jack Erion; Joseph E Bugaj; Ananth Srinivasan; Bert F Bernard; Dik J Kwekkeboom; Theo J Visser; Eric P Krenning
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(12):1650-6.
2002: Dharmin Nanda; Marion De Jong; Ronald Vogels; Menzo J E Havenga; Maarten J Driesse; Willem Bakker; Magda Bijster; Cees J J Avezaat; Peter Cox; Kevin Morin; Ebrahim Naimi; Edward Knaus; Leonard I Wiebe; Peter Sillevis Smitt
Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU.
European journal of nuclear medicine and molecular imaging 2002;29(7):939-47.
2002: Marion De Jong; Eric P Krenning
New advances in peptide receptor radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(5):617-20.
2002: Marion De Jong; Roelf Valkema; François Jamar; Larry K Kvols; Dik J Kwekkeboom; Wouter A P Breeman; Willem H Bakker; Chuck Smith; Stanislas Pauwels; Eric P Krenning
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
Seminars in nuclear medicine 2002;32(2):133-40.
2002: Roelf Valkema; Marion De Jong; Willem H Bakker; Wouter A P Breeman; Peter P M Kooij; Pieternella J Lugtenburg; Frank de Jong; Arjan Christiansen; Boen L Kam; Wouter W de Herder; Mats Stridsberg; Jan Lindemans; Geert Ensing; Eric P Krenning
Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience.
Seminars in nuclear medicine 2002;32(2):110-22.
2001: Marion De Jong; Wouter A P Breeman; Bert F Bernard; Willem H Bakker; Theo J Visser; Peter P M Kooij; Arthur van Gameren; Eric P Krenning
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(12):1841-6.
2001: Wouter A P Breeman; Marion De Jong; Dik J Kwekkeboom; Roelf Valkema; Willem H Bakker; Peter P M Kooij; Theo J Visser; Eric P Krenning
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.
European journal of nuclear medicine 2001;28(9):1421-9.
2001: Dik J Kwekkeboom; Willem H Bakker; Peter P M Kooij; M W Konijnenberg; Ananth Srinivasan; Jack Erion; Michelle A Schmidt; J L Bugaj; Marion De Jong; Eric P Krenning
[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.
European journal of nuclear medicine 2001;28(9):1319-25.
2001: Marion De Jong; Wouter A P Breeman; Bert F Bernard; Willem H Bakker; Michael Schaar; Arthur van Gameren; Joseph E Bugaj; Jack Erion; Michelle Schmidt; Ananth Srinivasan; Eric P Krenning
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
International journal of cancer. Journal international du cancer 2001;92(5):628-33.
2001: Gerrit D Slooter; Amir Mearadji; Wouter A P Breeman; Richard L Marquet; Marion De Jong; Eric P Krenning; C H J van Eijck
Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.
The British journal of surgery 2001;88(1):31-40.
2000: Bert F Bernard; Eric P Krenning; Wouter A P Breeman; Theo J Visser; Willem H Bakker; Ananth Srinivasan; Marion De Jong
Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
Nuclear medicine communications 2000;21(11):1079-85.
2000: Dik J Kwekkeboom; Eric P Krenning; Marion De Jong
Peptide receptor imaging and therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(10):1704-13.
2000: Dik J Kwekkeboom; Willem H Bakker; Peter P M Kooij; Jack Erion; Ananth Srinivasan; Marion De Jong; Jean Claude Reubi; Eric P Krenning
Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma.
European journal of nuclear medicine 2000;27(9):1312-7.
2000: P Martin van Hagen; Wouter A P Breeman; H F Bernard; Michael Schaar; C M Mooij; Ananth Srinivasan; Michelle A Schmidt; Eric P Krenning; Marion De Jong
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
International journal of cancer. Journal international du cancer 2000;90(4):186-98.
2000: Eric P Krenning; Marion De Jong
Therapeutic use of radiolabelled peptides.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 3():267-71.
2000: Eric P Krenning; Roelf Valkema; Peter P M Kooij; Wouter A P Breeman; Willem H Bakker; Wouter W de Herder; C H J van Eijck; Dik J Kwekkeboom; Marion De Jong; François Jamar; Stanislas Pauwels
The role of radioactive somatostatin and its analogues in the control of tumor growth.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2000;153():1-13.
1999: Marion De Jong; Wouter A P Breeman; H F Bernard; Peter P M Kooij; Gerrit D Slooter; C H J van Eijck; Dik J Kwekkeboom; Roelf Valkema; Helmut R Mäcke; Eric P Krenning
Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1999;43(4):356-66.
1999: Marion De Jong; Willem H Bakker; Bert F Bernard; Roelf Valkema; Dik J Kwekkeboom; Jean Claude Reubi; Ananth Srinivasan; Michelle Schmidt; Eric P Krenning
Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2081-7.
1999: Wouter A P Breeman; Marion De Jong; Bert F Bernard; Dik J Kwekkeboom; Ananth Srinivasan; ME van der Pluijm; Leo Hofland; Theo J Visser; Eric P Krenning
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy.
International journal of cancer. Journal international du cancer 1999;83(5):657-63.
1999: Marion De Jong; Wouter A P Breeman; Bert F Bernard; Arthur van Gameren; E de Bruin; Willem H Bakker; ME van der Pluijm; Theo J Visser; Helmut R Mäcke; Eric P Krenning
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount.
European journal of nuclear medicine 1999;26(7):693-8.
1999: Wouter A P Breeman; Leo Hofland; Marion De Jong; Bert F Bernard; Ananth Srinivasan; Dik J Kwekkeboom; Theo J Visser; Eric P Krenning
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
International journal of cancer. Journal international du cancer 1999;81(4):658-65.
1999: C H J van Eijck; Marion De Jong; Wouter A P Breeman; Gerrit D Slooter; Richard L Marquet; Eric P Krenning
Somatostatin receptor imaging and therapy of pancreatic endocrine tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 4():177-81.
1999: Eric P Krenning; Marion De Jong; Peter P M Kooij; Wouter A P Breeman; Willem H Bakker; Wouter W de Herder; C H J van Eijck; Dik J Kwekkeboom; François Jamar; Stanislas Pauwels; Roelf Valkema
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 2():S23-9.
1999: Leo J Hofland; Wouter A P Breeman; Eric P Krenning; Marion De Jong; Marlijn Waaijers; Peter M Van Koetsveld; Helmut R Mäcke; Steven W J Lamberts
Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery.
Proceedings of the Association of American Physicians 1999;111(1):63-9.
1998: Bert F Bernard; Eric P Krenning; Wouter A P Breeman; G Ensing; H Benjamins; Willem H Bakker; Theo J Visser; Marion De Jong
99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Nuclear medicine and biology 1998;25(3):233-40.
1998: Marion De Jong; Bert F Bernard; E De Bruin; Arthur van Gameren; Willem H Bakker; Theo J Visser; Helmut R Mäcke; Eric P Krenning
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
Nuclear medicine communications 1998;19(3):283-8.
1998: Marion De Jong; Wouter A P Breeman; Willem H Bakker; Peter P M Kooij; Bert F Bernard; Leo Hofland; Theo J Visser; Ananth Srinivasan; Michelle A Schmidt; Jack Erion; Joseph E Bugaj; Helmut R Mäcke; Eric P Krenning
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
Cancer research 1998;58(3):437-41.
1998: Marion De Jong; Willem H Bakker; Wouter A P Breeman; Bert F Bernard; Leo Hofland; Theo J Visser; Ananth Srinivasan; Michelle Schmidt; Martin Béhé; Helmut R Mäcke; Eric P Krenning
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
International journal of cancer. Journal international du cancer 1998;75(3):406-11.
1998: Wouter A P Breeman; Marion De Jong; B Bernard; Leo Hofland; Ananth Srinivasan; ME van der Pluijm; Willem H Bakker; Theo J Visser; Eric P Krenning
Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats.
Anticancer research 1998;18(1A):83-9.
1997: Bert F Bernard; Eric P Krenning; Wouter A P Breeman; Edgar J Rolleman; Willem H Bakker; Theo J Visser; Helmut R Mäcke; Marion De Jong
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1929-33.
1997: Wouter A P Breeman; Marion De Jong; Bert F Bernard; Willem H Bakker; Edgar J Rolleman; Dik J Kwekkeboom; Theo J Visser; Eric P Krenning
Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in rats.
Nuclear medicine and biology 1997;24(8):749-53.
1997: Marion De Jong; Willem H Bakker; Eric P Krenning; Wouter A P Breeman; ME van der Pluijm; Bert F Bernard; Theo J Visser; E Jermann; Martin Béhé; Pia Powell; Helmut R Mäcke
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy.
European journal of nuclear medicine 1997;24(4):368-71.
1996: Marion De Jong; Bert F Bernard; Wouter A P Breeman; G Ensing; H Benjamins; Willem H Bakker; Theo J Visser; Eric P Krenning
Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines.
European journal of nuclear medicine 1996;23(10):1361-6.
1996: Wouter A P Breeman; Willem H Bakker; Marion De Jong; Leo Hofland; Dik J Kwekkeboom; Peter P M Kooij; Theo J Visser; Eric P Krenning
Studies on radiolabeled somatostatin analogues in rats and in patients.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1996;40(3):209-20.
1996: Maria E Everts; Marion De Jong; C F Lim; Roel Docter; Eric P Krenning; Theo J Visser; Georg Hennemann
Different regulation of thyroid hormone transport in liver and pituitary: its possible role in the maintenance of low T3 production during nonthyroidal illness and fasting in man.
Thyroid : official journal of the American Thyroid Association 1996;6(4):359-68.
1996: Marion De Jong; Edgar J Rolleman; Bert F Bernard; Theo J Visser; Willem H Bakker; Wouter A P Breeman; Eric P Krenning
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(8):1388-92.
1996: Willem H Bakker; Wouter A P Breeman; ME van der Pluijm; Marion De Jong; Theo J Visser; Eric P Krenning
Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy.
European journal of nuclear medicine 1996;23(7):775-81.
1996: P G van Stralen; H J van der Hoek; Roel Docter; Marion De Jong; Eric P Krenning; Maria E Everts; Georg Hennemann
Uptake and metabolism of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine by human liver-derived cells: HepG2 cells as a model for thyroid hormone handling by human liver.
The Journal of clinical endocrinology and metabolism 1996;81(1):244-8.
1995: Maria E Everts; Theo J Visser; E P Moerings; AM Tempelaars; Hans van Toor; Roel Docter; Marion De Jong; Eric P Krenning; Georg Hennemann
Uptake of 3,3',5,5'-tetraiodothyroacetic acid and 3,3',5'-triiodothyronine in cultured rat anterior pituitary cells and their effects on thyrotropin secretion.
Endocrinology 1995;136(10):4454-61.
1995: R A Vos; Marion De Jong; Bert F Bernard; Roel Docter; Eric P Krenning; Georg Hennemann
Impaired thyroxine and 3,5,3'-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness.
The Journal of clinical endocrinology and metabolism 1995;80(8):2364-70.
1995: Marion De Jong; Wouter A P Breeman; Bert F Bernard; Edgar J Rolleman; Leo Hofland; Theo J Visser; B Setyono-Han; Willem H Bakker; ME van der Pluijm; Eric P Krenning
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy.
European journal of nuclear medicine 1995;22(7):608-16.
1995: Maria E Everts; C F Lim; E P Moerings; Roel Docter; Theo J Visser; Marion De Jong; Eric P Krenning; Georg Hennemann
Effects of a furan fatty acid and indoxyl sulfate on thyroid hormone uptake in cultured anterior pituitary cells.
The American journal of physiology 1995;268(5 Pt 1):E974-9.
1994: Maria E Everts; Theo J Visser; E P Moerings; Roel Docter; Hans van Toor; AM Tempelaars; Marion De Jong; Eric P Krenning; Georg Hennemann
Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells.
Endocrinology 1994;135(6):2700-7.
1994: Marion De Jong; Roel Docter; H van der Hoek; Eric P Krenning; Georg Hennemann
Adaptive changes in transmembrane transport and metabolism of triiodothyronine in perfused livers of fed and fasted hypothyroid and hyperthyroid rats.
Metabolism: clinical and experimental 1994;43(11):1355-61.
1994: Eric P Krenning; Dik J Kwekkeboom; Marion De Jong; Theo J Visser; J C Reubi; Willem H Bakker; Peter P M Kooij; Steven W J Lamberts
Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Seminars in oncology 1994;21(5 Suppl 13):6-14.
1994: Maria E Everts; Theo J Visser; J C van Buuren; Roel Docter; Marion De Jong; Eric P Krenning; Georg Hennemann
Uptake of triiodothyronine sulfate and suppression of thyrotropin secretion in cultured anterior pituitary cells.
Metabolism: clinical and experimental 1994;43(10):1282-6.
1994: Eric P Krenning; Peter P M Kooij; Willem H Bakker; Wouter A P Breeman; P T Postema; Dik J Kwekkeboom; H Y Oei; Marion De Jong; Theo J Visser; Ambroos E M Reijs
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Annals of the New York Academy of Sciences 1994;733():496-506.
1994: Maria E Everts; Roel Docter; E P Moerings; Peter M Van Koetsveld; Theo J Visser; Marion De Jong; Eric P Krenning; Georg Hennemann
Uptake of thyroxine in cultured anterior pituitary cells of euthyroid rats.
Endocrinology 1994;134(6):2490-7.
1994: Marion De Jong; Roel Docter; Bert F Bernard; J T van der Heijden; Hans van Toor; Eric P Krenning; Georg Hennemann
T4 uptake into the perfused rat liver and liver T4 uptake in humans are inhibited by fructose.
The American journal of physiology 1994;266(5 Pt 1):E768-75.
1994: Wouter A P Breeman; Leo Hofland; ME van der Pluijm; Peter M Van Koetsveld; Marion De Jong; B Setyono-Han; Willem H Bakker; Dik J Kwekkeboom; Theo J Visser; Steven W J Lamberts
A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
European journal of nuclear medicine 1994;21(4):328-35.
1994: C F Lim; Roel Docter; Eric P Krenning; Hans van Toor; B Bernard; Marion De Jong; Georg Hennemann
Transport of thyroxine into cultured hepatocytes: effects of mild non-thyroidal illness and calorie restriction in obese subjects.
Clinical endocrinology 1994;40(1):79-85.
1994: Marion De Jong; Roel Docter; H Van der Hoek; Eric P Krenning; D Van der Heide; C Quero; P Plaisier; R Vos; Georg Hennemann
Different effects of amiodarone on transport of T4 and T3 into the perfused rat liver.
The American journal of physiology 1994;266(1 Pt 1):E44-9.
1993: Roel Docter; Eric P Krenning; Marion De Jong; Georg Hennemann
The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism.
Clinical endocrinology 1993;39(5):499-518.
1993: Marion De Jong; Willem H Bakker; Wouter A P Breeman; ME van der Pluijm; Peter P M Kooij; Theo J Visser; R Docter; Eric P Krenning
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(11):2025-30.
1993: Georg Hennemann; R A Vos; Marion De Jong; Eric P Krenning; Roel Docter
Decreased peripheral 3,5,3'-triiodothyronine (T3) production from thyroxine (T4): a syndrome of impaired thyroid hormone activation due to transport inhibition of T4- into T3-producing tissues.
The Journal of clinical endocrinology and metabolism 1993;77(5):1431-5.
1993: Wouter A P Breeman; Leo Hofland; Willem H Bakker; ME van der Pluijm; Peter M Van Koetsveld; Marion De Jong; B Setyono-Han; Dik J Kwekkeboom; Theo J Visser; Steven W J Lamberts
Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.
European journal of nuclear medicine 1993;20(11):1089-94.
1993: Eric P Krenning; Dik J Kwekkeboom; Willem H Bakker; Wouter A P Breeman; Peter P M Kooij; H Y Oei; M van Hagen; P T Postema; Marion De Jong; J C Reubi
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
European journal of nuclear medicine 1993;20(8):716-31.
1993: Roel Docter; Hans van Toor; E P Krenning; Marion De Jong; Georg Hennemann
Free thyroxine assessed with three assays in sera of patients with nonthyroidal illness and of subjects with abnormal concentrations of thyroxine-binding proteins.
Clinical chemistry 1993;39(8):1668-74.
1993: Marion De Jong; Theo J Visser; Bert F Bernard; Roel Docter; R A Vos; Georg Hennemann; Eric P Krenning
Transport and metabolism of iodothyronines in cultured human hepatocytes.
The Journal of clinical endocrinology and metabolism 1993;77(1):139-43.
1993: P G van Stralen; H J van der Hoek; Roel Docter; Marion De Jong; Eric P Krenning; C F Lim; Georg Hennemann
Reduced T3 deiodination by the human hepatoblastoma cell line HepG2 caused by deficient T3 sulfation.
Biochimica et biophysica acta 1993;1157(1):114-8.
1993: C F Lim; Roel Docter; Theo J Visser; Eric P Krenning; B Bernard; Hans van Toor; Marion De Jong; Georg Hennemann
Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids.
The Journal of clinical endocrinology and metabolism 1993;76(5):1165-72.
1993: Maria E Everts; Roel Docter; J C van Buuren; Peter M Van Koetsveld; Leo Hofland; Marion De Jong; Eric P Krenning; Georg Hennemann
Evidence for carrier-mediated uptake of triiodothyronine in cultured anterior pituitary cells of euthyroid rats.
Endocrinology 1993;132(3):1278-85.
1993: C F Lim; Bert F Bernard; Marion De Jong; Roel Docter; Eric P Krenning; Georg Hennemann
A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
The Journal of clinical endocrinology and metabolism 1993;76(2):318-24.
1992: Marion De Jong; Roel Docter; H J Van Der Hoek; R A Vos; Eric P Krenning; Georg Hennemann
Transport of 3,5,3'-triiodothyronine into the perfused rat liver and subsequent metabolism are inhibited by fasting.
Endocrinology 1992;131(1):463-70.
1992: Eric P Krenning; Willem H Bakker; Peter P M Kooij; Wouter A P Breeman; H Y Oei; Marion De Jong; J C Reubi; Theo J Visser; Christian Bruns; Dik J Kwekkeboom
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(5):652-8.
1991: Willem H Bakker; Eric P Krenning; Wouter A P Breeman; Peter P M Kooij; J C Reubi; Jan W Koper; Marion De Jong; J S Laméris; Theo J Visser; Steven W J Lamberts
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(6):1184-9.
1991: J B Beetstra; J G van Engelen; P Karels; H J van der Hoek; Marion De Jong; Roel Docter; Eric P Krenning; Georg Hennemann; A Brouwer; T J Visser
Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases.
Endocrinology 1991;128(2):741-6.
1991: R Den Toom; Marion De Jong; Eric P Krenning; H J Van der Hoek; F J Ten Kate; Georg Hennemann; Onno T Terpstra
Euro-Collins solution versus UW-solution for long-term liver preservation in the isolated rat-liver perfusion model.
HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 1991;4(4):313-20.
1991: Willem H Bakker; Eric P Krenning; J C Reubi; Wouter A P Breeman; B Setyono-Han; Marion De Jong; Peter P M Kooij; Christian Bruns; P Martin van Hagen; P Marbach
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
Life sciences 1991;49(22):1593-601.
1990: Roel Docter; Marion De Jong; H J van der Hoek; Eric P Krenning; Georg Hennemann
Development and use of a mathematical two-pool model of distribution and metabolism of 3,3',5-triiodothyronine in a recirculating rat liver perfusion system: albumin does not play a role in cellular transport.
Endocrinology 1990;126(1):451-9.